← FDA Drug Approvals (Drugs@FDA)

VOSEVI

NDA · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2017-07-18

Drug application

FDA Application #

NDA209195

Application type

New Drug Application

Brand name

VOSEVI

Generic name

SOFOSBUVIR, VELPATASVIR, AND VOXILAPREVIR

Active ingredients

SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GILEAD SCIENCES INC

Manufacturer

Gilead Sciences, Inc.

First approval

2017-07-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown